Spinocerebellar ataxia type 10

MONDO:0011330

Spinocerebellar ataxia type 10 (SCA10) is a subtype of type I autosomal dominant cerebellar ataxia (ADCA type I). It is characterized by slowly progressive cerebellar syndrome and epilepsy, sometimes mild pyramidal signs, peripheral neuropathy and neuropsychological disturbances.

Also known as: SCA10, spinocerebellar ataxia type 10, spinocerebellar ataxia 10

23 clinical trials for this condition and its sub-types, 4 tagged with Spinocerebellar ataxia type 10 itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Autosomal dominant cerebellar ataxia type IV (8)

Including sub-types (23) Tagged with Spinocerebellar ataxia type 10 (4)

Trials to join now! 1 Not yet finished but already full! 2 Completed 1

Hope for ataxia: experimental drug shows promise in Late-Stage trial

Disease control Completed

This study tested a drug called troriluzole in 141 adults with spinocerebellar ataxia, a rare disease that affects balance and coordination. Participants took either the drug or a placebo daily for 8 weeks. The main goal was to see if troriluzole could improve symptoms like walki…

Phase 2/3 • Sponsor: Biohaven Pharmaceuticals, Inc. • Aim: Disease control

Last updated Jun 27, 2026 07:53 UTC

Spinocerebellar ataxia type 10

Where it sits in the disease tree

Hope for ataxia: experimental drug shows promise in Late-Stage trial